Alphabetical Listing by Company Name
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Group Information
Group information AngloGold Limited was founded in June 1998 through the consolidation of the gold mining interests of Anglo American. The company, AngloGold Ashanti as it is now, was formed on 26 April 2004 following the business combination between AngloGold and Ashanti Goldfields Company Limited. AngloGold Ashanti is currently the third largest gold producing mining company in the world. CURRENT PROFILE AngloGold Ashanti Limited, headquartered in Johannesburg, South Africa, is a global gold company with a portfolio of long-life, relatively low-cost assets and differing orebody types in key gold producing regions. The company's 21 operations are located in 10 countries (Argentina, Australia, Brazil, Ghana, Guinea, Mali, Namibia, South Africa, Tanzania and the United States of America), and are supported by extensive exploration activities. The combined Proved and Probable Ore Reserves of the group amounted to 74.9 million ounces as at 31 December 2008. The primary listing of the company's ordinary shares is on the JSE Limited (JSE) in South Africa. Its ordinary shares are also listed on stock exchanges in London, Paris and Ghana, as well as being quoted in Brussels in the form of International Depositary Receipts (IDRs), in New York in the form of American Depositary Shares (ADSs), in Australia, in the form of Clearing House Electronic Subregister System Depositary Interests (CDIs) and in Ghana, in the form of Ghanaian Depositary Shares (GhDSs). AngloGold Ashanti Limited (Registration number 1944/017354/06) was incorporated in the Republic of South Africa in 1944 under the name of Vaal Reefs Exploration and Mining Company Limited and operates under the South African Companies Act 61 of 1973, as amended. -
R Trader Instruments Cfds and Stocks
DE SHARES Ticker Company Ticker Company Ticker Company 1COV.DE COVESTRO AG FNTN.DE FREENET AG P1Z.DE PATRIZIA IMMOBILIEN AG AAD.DE AMADEUS FIRE AG FPE.DE FUCHS PETROLUB vz PBB.DE DEUTSCHE PFANDBRIEFBANK AG ACX1.DE BET-AT-HOME.COM AG FRA.DE FRAPORT AG FRANKFURT AIRPORTPFV.DE PFEIFFER VACUUM TECHNOLOGY ADJ.DE ADO PROPERTIES FRE.DE FRESENIUS PSM.DE PROSIEBENSAT.1 MEDIA SE ADL.DE ADLER REAL ESTATE AG G1A.DE GEA PUM.DE PUMA SE ADS.DE ADIDAS AG G24.DE SCOUT24 AG QIA.DE QIAGEN N.V. ADV.DE ADVA OPTICAL NETWORKING SE GBF.DE BILFINGER SE RAA.DE RATIONAL AFX.DE CARL ZEISS MEDITEC AG - BR GFT.DE GFT TECHNOLOGIES SE RHK.DE RHOEN-KLINIKUM AG AIXA.DE AIXTRON SE GIL.DE DMG MORI RHM.DE RHEINMETALL AG ALV.DE ALLIANZ SE GLJ.DE GRENKE RIB1.DE RIB SOFTWARE SE AM3D.DE SLM SOLUTIONS GROUP AG GMM.DE GRAMMER AG RKET.DE ROCKET INTERNET SE AOX.DE ALSTRIA OFFICE REIT-AG GWI1.DE GERRY WEBER INTL AG S92.DE SMA SOLAR TECHNOLOGY AG ARL.DE AAREAL BANK AG GXI.DE GERRESHEIMER AG SAX.DE STROEER SE & CO KGAA BAS.DE BASF SE HAB.DE HAMBORNER REIT SAZ.DE STADA ARZNEIMITTEL AG BAYN.DE BAYER AG HBM.DE HORNBACH BAUMARKT AG SFQ.DE SAF HOLLAND S.A. BC8.DE BECHTLE AG HDD.DE HEIDELBERGER DRUCKMASCHINENSGL.DE SGL CARBON SE BDT.DE BERTRANDT AG HEI.DE HEIDELBERGCEMENT AG SHA.DE SCHAEFFLER AG BEI.DE BEIERSDORF AG HEN3.DE HENKEL AG & CO KGAA SIE.DE SIEMENS AG BIO4.DE BIOTEST AG HLAG.DE HAPAG-LLOYD AG SIX2.DE SIXT SE BMW.DE BAYERISCHE MOTOREN WERKE AGHLE.DE HELLA KGAA HUECK & CO SKB.DE KOENIG & BAUER AG BNR.DE BRENNTAG AG HNR1.DE HANNOVER RUECK SE SPR.DE AXEL SPRINGER SE BOSS.DE HUGO BOSS -
Top 20 Largest - Consolidated Short Position Report
Top 20 Largest - Consolidated Short Position Report Please find below the Top 20 Largest Consolidated Short Position Report Highlights. The report is produced twice monthly, effective the 15th and the end of each month. The report below covers the 2-week period ending December 31, 2013. TSX Markets (a division of TSX Inc.) collects this information on behalf of Investment Industry Organization of Canada. Participating Organizations are required to file this information pursuant to Universal Market Integrity Rule 10.10. Issue Name Symbol As of Dec 30 As of Dec 15 Net Change LUNDIN MINING CORPORATION LUN 60,372,644 62,894,431 -2,521,787 BOMBARDIER INC. CL B SV BBD.B 52,650,735 33,988,500 18,662,235 NEW GOLD INC. NGD 46,377,287 47,205,108 -827,821 OSISKO MINING CORPORATION J OSK 43,675,171 43,720,790 -45,619 THOMSON REUTERS CORPORATION TRI 41,633,981 28,979,682 12,654,299 ATHABASCA OIL CORPOATION J ATH 37,568,553 38,388,408 -819,855 MANULIFE FINANCIAL CORPORATION MFC 37,428,824 46,959,284 -9,530,460 BARRICK GOLD CORPORATION ABX 32,416,329 24,026,847 8,389,482 BROOKFIELD OFFICE PROPERTIES INC. BPO 32,255,989 20,777,738 11,478,251 HUSKY ENERGY INC. HSE 29,269,593 26,681,348 2,588,245 LEGACY OIL + GAS INC. LEG 29,210,825 29,114,197 96,628 CELESTICA INC. SV CLS 28,638,415 36,833,550 -8,195,135 BCE INC. BCE 28,544,803 24,118,117 4,426,686 GREAT-WEST LIFECO INC. -
Retirement Strategy Fund 2060 Description Plan 3S DCP & JRA
Retirement Strategy Fund 2060 June 30, 2020 Note: Numbers may not always add up due to rounding. % Invested For Each Plan Description Plan 3s DCP & JRA ACTIVIA PROPERTIES INC REIT 0.0137% 0.0137% AEON REIT INVESTMENT CORP REIT 0.0195% 0.0195% ALEXANDER + BALDWIN INC REIT 0.0118% 0.0118% ALEXANDRIA REAL ESTATE EQUIT REIT USD.01 0.0585% 0.0585% ALLIANCEBERNSTEIN GOVT STIF SSC FUND 64BA AGIS 587 0.0329% 0.0329% ALLIED PROPERTIES REAL ESTAT REIT 0.0219% 0.0219% AMERICAN CAMPUS COMMUNITIES REIT USD.01 0.0277% 0.0277% AMERICAN HOMES 4 RENT A REIT USD.01 0.0396% 0.0396% AMERICOLD REALTY TRUST REIT USD.01 0.0427% 0.0427% ARMADA HOFFLER PROPERTIES IN REIT USD.01 0.0124% 0.0124% AROUNDTOWN SA COMMON STOCK EUR.01 0.0248% 0.0248% ASSURA PLC REIT GBP.1 0.0319% 0.0319% AUSTRALIAN DOLLAR 0.0061% 0.0061% AZRIELI GROUP LTD COMMON STOCK ILS.1 0.0101% 0.0101% BLUEROCK RESIDENTIAL GROWTH REIT USD.01 0.0102% 0.0102% BOSTON PROPERTIES INC REIT USD.01 0.0580% 0.0580% BRAZILIAN REAL 0.0000% 0.0000% BRIXMOR PROPERTY GROUP INC REIT USD.01 0.0418% 0.0418% CA IMMOBILIEN ANLAGEN AG COMMON STOCK 0.0191% 0.0191% CAMDEN PROPERTY TRUST REIT USD.01 0.0394% 0.0394% CANADIAN DOLLAR 0.0005% 0.0005% CAPITALAND COMMERCIAL TRUST REIT 0.0228% 0.0228% CIFI HOLDINGS GROUP CO LTD COMMON STOCK HKD.1 0.0105% 0.0105% CITY DEVELOPMENTS LTD COMMON STOCK 0.0129% 0.0129% CK ASSET HOLDINGS LTD COMMON STOCK HKD1.0 0.0378% 0.0378% COMFORIA RESIDENTIAL REIT IN REIT 0.0328% 0.0328% COUSINS PROPERTIES INC REIT USD1.0 0.0403% 0.0403% CUBESMART REIT USD.01 0.0359% 0.0359% DAIWA OFFICE INVESTMENT -
The Advisory Committee for the FTSE Med-100 Index, Had Its Semi-Annual Meeting Today, 14Th of November 2012
The Advisory Committee for the FTSE Med-100 Index, had its semi-annual meeting today, 14th of November 2012. The FTSE Med-100 Index which was launched on the 19/6/2003 is composed of 100 stocks of three Exchanges (Athens Exchange, Tel-Aviv Stock Exchange and Cyprus Stock Exchange). The Advisory Committee of the index is comprised of representatives from the three Exchanges and also from the global index provider “FTSE Group”. During this meeting, the committee reviewed the operation of the index for the six months period between May 2012 – October 2012, in accordance with its ground rules, which follow international standards. Having applied the index rules, no changes are applicable in the constituent list of the index. The index is composed of 65 stocks listed on the Tel-Aviv Stock Exchange, 22 stocks listed on the Athens Exchange and 13 stocks listed on the Cyprus Stock Exchange. The list of the constituent 100 companies is as follows: Country Capital value (Euro million) 1 Teva Pharmaceutical Israel 27.292,7 2 Israel Chemicals Israel 12.219,9 3 Coca-Cola HBC Greece 6.031,4 4 Israel Corporation Israel 4.035,7 5 Bank Hapoalim Israel 3.986,6 6 Bank Leumi Israel 3.646,5 7 Bezeq Israel 2.556,6 8 Azrieli Group Israel 2.097,3 9 Mellanox Technologies Israel 1.947,6 10 Hellenic Petroleum (Cr) Greece 1.845,0 11 Natl Bank Of Greece Greece 1.710,1 12 Hellenic Telecom Greece 1.670,3 13 Delek Group Israel 1.668,5 14 Nice Systems Israel 1.603,7 15 Mizrahi Tefahot Bank Ltd. -
White Phosphorus (WP) and Smoke Mortars in 60Mm, 81Mm and 120Mm Calibers, Equipped with Point Detonating, Proximity and Electronic Time Fuses
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2010 Commission File No. 0-28998 ELBIT SYSTEMS LTD. (Exact name of registrant as specified in its charter and translation of registrant’s name into English) Israel (Jurisdiction of incorporation or organization) Advanced Technology Center, Haifa 31053, Israel (Address of principal executive offices) Joseph Gaspar c/o Elbit Systems Ltd. P.O. Box 539 Advanced Technology Center Haifa 31053 Israel Tel: 972-4-831-6404 Fax: 972-4-831-6944 E-mail: [email protected] (Name, telephone, e-mail and/or facsimile number and address of Company contact person) Securities registered or to be registered pursuant to Section 12(b) of the Act: Ordinary Shares, nominal value 1.0 New Israeli Shekels per share (Title of Class) The NASDAQ Global Select Market (Name of each Exchange on which registered) Securities registered or to be registered pursuant to Section 12(g) of the Act: Not Applicable Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: Not Applicable Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 42,693,340 Ordinary Shares Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No o If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. -
Elbit Medical Technologies Initiation of Coverage
Elbit Medical Technologies Initiation of coverage Two promising private assets Pharma & biotech 28 June 2018 Elbit Medical Technologies is an Israel-based healthcare investment company traded on the TASE. It is invested in two private companies: Price* NIS1.12 InSightec is a commercial-stage medical device company marketing a non- Market cap NIS259m invasive thermal tissue ablation therapy in three indications and Gamida *Priced as at 26 June 2018 Cell is a cell and immune therapy company developing a universal bone NIS3.64/US$ marrow transplant (BMT) product for haematological malignancies. Net debt ($m) at 31 December 2017 42.4 Although their recent offerings of NIS182m of convertible notes lengthen Shares in issue 231.4m the cash runway it raises the prospect of dilution in 2022. In addition, the Free float 10.8% parent company Elbit Imaging (~89% owned) has its own challenges. We value Elbit Medical at NIS407m or NIS1.76 per share. Code EMTC Primary exchange TASE Revenue PBT* EPS* DPS P/E Yield Secondary exchange N/A Year end ($m) ($m) ($) ($) (x) (%) 12/15 1.8 (1.1) 0.0 0.0 N/A N/A Share price performance 12/16 0.0 (3.7) 0.0 0.0 N/A N/A 12/17 0.0 (5.2) 0.0 0.0 N/A N/A Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments. InSightec: A non-invasive operating room Elbit Medical currently holds a ~22% (~19% fully diluted) stake in InSightec, a commercial-stage medical device company. -
NASDAQ Stock Market
Nasdaq Stock Market Friday, December 28, 2018 Name Symbol Close 1st Constitution Bancorp FCCY 19.75 1st Source SRCE 40.25 2U TWOU 48.31 21st Century Fox Cl A FOXA 47.97 21st Century Fox Cl B FOX 47.62 21Vianet Group ADR VNET 8.63 51job ADR JOBS 61.7 111 ADR YI 6.05 360 Finance ADR QFIN 15.74 1347 Property Insurance Holdings PIH 4.05 1-800-FLOWERS.COM Cl A FLWS 11.92 AAON AAON 34.85 Abiomed ABMD 318.17 Acacia Communications ACIA 37.69 Acacia Research - Acacia ACTG 3 Technologies Acadia Healthcare ACHC 25.56 ACADIA Pharmaceuticals ACAD 15.65 Acceleron Pharma XLRN 44.13 Access National ANCX 21.31 Accuray ARAY 3.45 AcelRx Pharmaceuticals ACRX 2.34 Aceto ACET 0.82 Achaogen AKAO 1.31 Achillion Pharmaceuticals ACHN 1.48 AC Immune ACIU 9.78 ACI Worldwide ACIW 27.25 Aclaris Therapeutics ACRS 7.31 ACM Research Cl A ACMR 10.47 Acorda Therapeutics ACOR 14.98 Activision Blizzard ATVI 46.8 Adamas Pharmaceuticals ADMS 8.45 Adaptimmune Therapeutics ADR ADAP 5.15 Addus HomeCare ADUS 67.27 ADDvantage Technologies Group AEY 1.43 Adobe ADBE 223.13 Adtran ADTN 10.82 Aduro Biotech ADRO 2.65 Advanced Emissions Solutions ADES 10.07 Advanced Energy Industries AEIS 42.71 Advanced Micro Devices AMD 17.82 Advaxis ADXS 0.19 Adverum Biotechnologies ADVM 3.2 Aegion AEGN 16.24 Aeglea BioTherapeutics AGLE 7.67 Aemetis AMTX 0.57 Aerie Pharmaceuticals AERI 35.52 AeroVironment AVAV 67.57 Aevi Genomic Medicine GNMX 0.67 Affimed AFMD 3.11 Agile Therapeutics AGRX 0.61 Agilysys AGYS 14.59 Agios Pharmaceuticals AGIO 45.3 AGNC Investment AGNC 17.73 AgroFresh Solutions AGFS 3.85 -
Incoming Letter: QIAGEN N.V
WACHTELL, LIPTON , ROSEN & KATZ MARTIN LIPTON STEVEN A. COHEN 51 W E S T 52N D S T R E E T DAVID E. SHAPIRO SABASTIAN V. NILES HERBERT M. WACHTELL DEBORAH L. PAUL DAMIAN G. DIDDEN ALISON ZIESKE PREISS THEODORE N. MIRVIS DAVID C. KARP NEW YORK, N.Y. 1 0 0 1 9 - 6 1 5 0 IAN B OC Z K O TIJANA J. DVORNIC EDWARD D. HERLIHY RICHARD K. KIM MATTHEW M. GUEST JENNA E. LEVINE DANIEL A. NEFF JOSHUA R. CAMMAKER TELEPHONE: (212) 403 -1000 DAVID E. KAHAN RYAN A. McLEOD ANDREW R. BROWNSTEIN MARK GORDON DAVID K. LAM ANITHA REDDY MARC WOLINSKY JOSEPH D. LARSON FACSIMILE: (212) 403 -2000 BENJAMIN M. ROTH JOHN L. ROBINSON STEVEN A. ROSENBLUM JEANNEMARIE O’BRIEN JOSHUA A. FELTMAN JOHN R. SOBOLEWSKI JOHN F. SAVARESE WAYNE M. CARLIN GEORGE A. KATZ (1965 -1 9 8 9) ELAINE P. GOLIN STEVEN WINTER SCOTT K. CHARLES STEPHEN R. D iPRIMA JAMES H. FOGELSON (1967 - 1 9 91) EMI L A. KLEINHAUS EMILY D. JOHNSON JODI J. SCHWARTZ NICHOLAS G. DEMMO LEONARD M. ROSEN (1965 - 2 0 14 ) KARESSA L. CAIN JACOB A. KLING ADAM O. EMMERICH IGOR KIRMAN RONALD C. CHEN RAAJ S. NARAYAN RALPH M. LEVENE JONATHAN M. MOSES OF C O UN S EL GORDON S. MOODIE VIKTOR SAPEZHNIKOV RICHARD G. MASON T. EIKO STANGE DONGJU SONG MICHAEL J. SCHOBEL MARTIN J.E. ARMS ERIC S. ROBINSON DAVID M. SILK JOHN F. LYNCH BRADLEY R. WILSON ELINA TETELBAUM MICHAEL H. BYOWITZ PATRICIA A. ROBINSON* ROBIN PANOVKA WILLIAM SAVITT GRAHAM W. -
Walmart Canada's
Walmart Canada’s Corporate Social Responsibility Report Environment People Ethical Sourcing Community Published September 2011 Introduction Corporate Social Responsibility Report Published September 2011 Message from the President and CEO Welcome to our latest CSR Report. This year’s theme is collaboration – it’s about working with our corporate peers, stakeholders, and even retail competitors to pursue the solutions to challenges which concern us all. We see this report as a powerful tool for corporate good. Our size gives us considerable influence and with it comes considerable responsibility – a role we embrace in order to help Canadians save money and live better. Our goal is to present an open look into the impact of our operations in Canada over the past year. This latest report frames our diverse activities into four broad categories of CSR: Environment, People, Ethical Sourcing and Community. In each area, we highlight our efforts and actions, both large and small – and summarize our current programs and challenges while outlining plans to keep improving in the future. Now ready to share this report with stakeholders, we are tremendously proud of the progress to date but equally aware of how much is still left to do. In the spirit of collaboration that permeates this report, I welcome your feedback to help us better pursue and attain our goals. David Cheesewright President and CEO, Walmart Canada What to look for in our 2011 CSR Report: Key Performance Indicators (KPIs) .........................................................................................................................3 -
List of Section 13F Securities
List of Section 13F Securities 1st Quarter FY 2004 Copyright (c) 2004 American Bankers Association. CUSIP Numbers and descriptions are used with permission by Standard & Poors CUSIP Service Bureau, a division of The McGraw-Hill Companies, Inc. All rights reserved. No redistribution without permission from Standard & Poors CUSIP Service Bureau. Standard & Poors CUSIP Service Bureau does not guarantee the accuracy or completeness of the CUSIP Numbers and standard descriptions included herein and neither the American Bankers Association nor Standard & Poor's CUSIP Service Bureau shall be responsible for any errors, omissions or damages arising out of the use of such information. U.S. Securities and Exchange Commission OFFICIAL LIST OF SECTION 13(f) SECURITIES USER INFORMATION SHEET General This list of “Section 13(f) securities” as defined by Rule 13f-1(c) [17 CFR 240.13f-1(c)] is made available to the public pursuant to Section13 (f) (3) of the Securities Exchange Act of 1934 [15 USC 78m(f) (3)]. It is made available for use in the preparation of reports filed with the Securities and Exhange Commission pursuant to Rule 13f-1 [17 CFR 240.13f-1] under Section 13(f) of the Securities Exchange Act of 1934. An updated list is published on a quarterly basis. This list is current as of March 15, 2004, and may be relied on by institutional investment managers filing Form 13F reports for the calendar quarter ending March 31, 2004. Institutional investment managers should report holdings--number of shares and fair market value--as of the last day of the calendar quarter as required by Section 13(f)(1) and Rule 13f-1 thereunder. -
Adapting to Climate Change: a Guide for the Mining Industry
Adapting to Climate Change: A Guide for the Mining Industry Julia Nelson, Manager, Advisory Services Ryan Schuchard, Manager, Climate and Energy This guide is part of a BSR This primer on climate change adaptation summarizes how companies in the industry series. For additional mining industry are reporting on climate change risks and opportunities, and highlights current and emerging best practices and guidance for E&U companies climate adaptation briefs, please visit www.bsr.org/adaptation. on how to develop a proactive approach to climate change adaptation. In this brief, mining refers to companies involved in the extraction of a broad range of metals and minerals, including precious metals, base metals, industrial Contents and Methodology minerals, coal, and uranium. This brief covers: Introduction Reporting on Risks and Opportunities: A synopsis Due to the wide geographic distribution of mining operations, climate change, including temperature and precipitation shifts as well as more frequent and based on reporting of climate severe extreme weather events, will have complex impacts on the sector. risk in 2009 by 41 mining Climactic conditions will affect the stability and effectiveness of infrastructure and companies to the Carbon equipment, environmental protection and site closure practices, and the Disclosure Project (CDP). availability of transportation routes. Climate change may also impact the stability and cost of water and energy supplies. Current Practices: An outline of actions related to climate Some examples: Warming temperatures will increase water scarcity in some change adaptation based on locations, inhibiting water-dependent operations, complicating site rehabilitation reporting from the CDP, and bringing companies into direct conflict with communities for water resources.